SINOPHARM CAPITAL
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and is based in Shanghai, China.
SINOPHARM CAPITAL
Social Links:
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
2012-06-01
Status:
Active
Contact:
86 21 6333 7900
Email Addresses:
[email protected]
Technology used in webpage:
GlobalSign Alibaba Tengine HiChina
Similar Organizations
Color Capital
Color Capital invests in things people buy, and how they buy them.
Oceanpine Capital
Oceanpine Capital is a professional investment management firm dedicated to long-term investment with a focus on value creation.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-23 | MXB Biotechnologies | MXB Biotechnologies acquired by Sinopharm Capital | 2.63 B CNY |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | Metanovas | Sinopharm Capital investment in Seed Round - Metanovas | 10 M USD |
| 2022-03-31 | Artivila Therapeutics | Sinopharm Capital investment in Seed Round - Artivila Therapeutics | 100 M CNY |
| 2021-12-13 | Xishan | Sinopharm Capital investment in Series D - Xishan | 100 M CNY |
| 2021-12-07 | Sumgen Biotech | Sinopharm Capital investment in Venture Round - Sumgen Biotech | N/A |
| 2021-11-26 | Longhui Medical | Sinopharm Capital investment in Series B - Longhui Medical | 100 M CNY |
| 2021-11-15 | Sepax Technologies | Sinopharm Capital investment in Series D - Sepax Technologies | 500 M CNY |
| 2021-11-02 | Shanghai Ouyi Biomedical Technology | Sinopharm Capital investment in Series A - Shanghai Ouyi Biomedical Technology | 100 M CNY |
| 2021-10-01 | Brise Pharma | Sinopharm Capital investment in Angel Round - Brise Pharma | 150 M CNY |
| 2021-09-28 | Geneus | Sinopharm Capital investment in Series B - Geneus | N/A |
| 2021-05-06 | Yikon Genomics | Sinopharm Capital investment in Series D - Yikon Genomics | 250 M CNY |